Optimization of bioprocess conditions improves production of a CHO cell‐derived, bioengineered heparin

Publisher: John Wiley & Sons Inc

E-ISSN: 1860-7314|10|7|1067-1081

ISSN: 1860-6768

Source: BIOTECHNOLOGY JOURNAL (ELECTRONIC), Vol.10, Iss.7, 2015-07, pp. : 1067-1081

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract